CN1849116A - 用于治疗疼痛的氨基甲酸酯化合物 - Google Patents

用于治疗疼痛的氨基甲酸酯化合物 Download PDF

Info

Publication number
CN1849116A
CN1849116A CNA028089227A CN02808922A CN1849116A CN 1849116 A CN1849116 A CN 1849116A CN A028089227 A CNA028089227 A CN A028089227A CN 02808922 A CN02808922 A CN 02808922A CN 1849116 A CN1849116 A CN 1849116A
Authority
CN
China
Prior art keywords
pain
formula
enantiomer
phenyl
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028089227A
Other languages
English (en)
Chinese (zh)
Inventor
C·R·普拉塔-萨拉曼
赵柏羽
R·E·特伊曼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Publication of CN1849116A publication Critical patent/CN1849116A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CNA028089227A 2001-02-27 2002-02-21 用于治疗疼痛的氨基甲酸酯化合物 Pending CN1849116A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27188801P 2001-02-27 2001-02-27
US60/271,888 2001-02-27

Publications (1)

Publication Number Publication Date
CN1849116A true CN1849116A (zh) 2006-10-18

Family

ID=23037511

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028089227A Pending CN1849116A (zh) 2001-02-27 2002-02-21 用于治疗疼痛的氨基甲酸酯化合物

Country Status (28)

Country Link
US (1) US6815464B2 (cg-RX-API-DMAC10.html)
EP (1) EP1404312B1 (cg-RX-API-DMAC10.html)
JP (1) JP4276838B2 (cg-RX-API-DMAC10.html)
KR (1) KR100906315B1 (cg-RX-API-DMAC10.html)
CN (1) CN1849116A (cg-RX-API-DMAC10.html)
AR (1) AR033427A1 (cg-RX-API-DMAC10.html)
AT (1) ATE493125T1 (cg-RX-API-DMAC10.html)
AU (1) AU2002254015B2 (cg-RX-API-DMAC10.html)
BR (1) BR0207673A (cg-RX-API-DMAC10.html)
CA (1) CA2439274C (cg-RX-API-DMAC10.html)
CY (1) CY1111349T1 (cg-RX-API-DMAC10.html)
CZ (1) CZ20032298A3 (cg-RX-API-DMAC10.html)
DE (1) DE60238765D1 (cg-RX-API-DMAC10.html)
DK (1) DK1404312T3 (cg-RX-API-DMAC10.html)
ES (1) ES2356617T3 (cg-RX-API-DMAC10.html)
HU (1) HUP0303236A3 (cg-RX-API-DMAC10.html)
IL (1) IL157593A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA03007721A (cg-RX-API-DMAC10.html)
MY (1) MY129312A (cg-RX-API-DMAC10.html)
NO (1) NO20033804L (cg-RX-API-DMAC10.html)
NZ (1) NZ527994A (cg-RX-API-DMAC10.html)
PL (1) PL364647A1 (cg-RX-API-DMAC10.html)
PT (1) PT1404312E (cg-RX-API-DMAC10.html)
RS (1) RS67603A (cg-RX-API-DMAC10.html)
RU (1) RU2283106C2 (cg-RX-API-DMAC10.html)
TW (1) TWI304735B (cg-RX-API-DMAC10.html)
WO (1) WO2002067922A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200307475B (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102266317A (zh) * 2011-06-24 2011-12-07 中国人民解放军第三军医大学 丙戊酸及其衍生物的应用

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003007934A1 (en) * 2001-07-16 2003-01-30 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
EP1998781A2 (en) * 2006-03-24 2008-12-10 Wyeth a Corporation of the State of Delaware Treatment of pain
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2011032175A1 (en) 2009-09-14 2011-03-17 Nuon Therapeutics, Inc. Combination formulations of tranilast and allopurinol and methods related thereto
EP2496227B1 (en) 2009-11-06 2019-05-22 SK Biopharmaceuticals Co., Ltd. Methods for treating fibromyalgia syndrome
ES2447295T3 (es) 2009-11-06 2014-03-11 Sk Biopharmaceuticals Co., Ltd. Métodos para el tratamiento del trastorno de déficit de atención/hiperactividad
US8623913B2 (en) 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
RU2632659C2 (ru) * 2011-12-27 2017-10-09 Байо-Фарм Солюшнс Ко., Лтд. Фенилкарбаматные соединения для применения в предупреждении или лечении эпилепсии
JP6062077B2 (ja) 2013-03-12 2017-01-18 バイオ−ファーム ソリューションズ カンパニー リミテッド 小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物{phenylcarbamatecompoundsforuseinpreventingortreatingpediatricepilesyandepilesy−relatedsyndromes}
KR102421013B1 (ko) * 2016-05-19 2022-07-14 에스케이바이오팜 주식회사 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
RU2020972C1 (ru) * 1991-02-07 1994-10-15 Мегдятов Рашид Салехович Способ лечения невралгии тройничного нерва
US5698588A (en) 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
ATE226071T1 (de) * 1996-10-08 2002-11-15 Ortho Mcneil Pharm Inc Antikonvulsive derivate zur behandlung von neuropathischem schmerz
GB2340074A (en) * 1998-08-01 2000-02-16 Max Imaging Systems Limited Printing process
PL365701A1 (en) 2000-07-21 2005-01-10 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102266317A (zh) * 2011-06-24 2011-12-07 中国人民解放军第三军医大学 丙戊酸及其衍生物的应用

Also Published As

Publication number Publication date
KR100906315B1 (ko) 2009-07-07
JP2004523553A (ja) 2004-08-05
CZ20032298A3 (cs) 2004-08-18
AU2002254015B2 (en) 2006-08-24
ATE493125T1 (de) 2011-01-15
NO20033804L (no) 2003-09-30
RU2003128984A (ru) 2005-03-20
CA2439274C (en) 2011-04-05
WO2002067922A1 (en) 2002-09-06
PL364647A1 (en) 2004-12-13
TWI304735B (en) 2009-01-01
MXPA03007721A (es) 2004-11-12
KR20030076711A (ko) 2003-09-26
RU2283106C2 (ru) 2006-09-10
CA2439274A1 (en) 2002-09-06
JP4276838B2 (ja) 2009-06-10
NO20033804D0 (no) 2003-08-26
CY1111349T1 (el) 2015-08-05
EP1404312A1 (en) 2004-04-07
NZ527994A (en) 2005-11-25
US20020156127A1 (en) 2002-10-24
US6815464B2 (en) 2004-11-09
RS67603A (sr) 2007-02-05
MY129312A (en) 2007-03-30
EP1404312B1 (en) 2010-12-29
IL157593A0 (en) 2004-03-28
DK1404312T3 (da) 2011-03-14
AR033427A1 (es) 2003-12-17
DE60238765D1 (de) 2011-02-10
ZA200307475B (en) 2005-01-03
HUP0303236A3 (en) 2012-07-30
BR0207673A (pt) 2004-12-28
ES2356617T3 (es) 2011-04-11
PT1404312E (pt) 2011-02-01
HUP0303236A2 (hu) 2004-01-28

Similar Documents

Publication Publication Date Title
US6589986B2 (en) Methods of treating anxiety disorders
JP5901528B2 (ja) 線維筋痛症候群の治療方法
CN1505508A (zh) 用于预防或治疗运动障碍的氨基甲酸酯化合物
JP4276838B2 (ja) 疼痛(pain)の治療における使用のためのカルバメート化合物
CN1235579C (zh) 用于预防或治疗神经变性疾病的氨基甲酸酯化合物
AU2002254015A1 (en) Carbamate compounds for use in the treatment of pain
CN1503665A (zh) 用于预防或治疗焦虑症的氨基甲酸酯化合物
CN101272776A (zh) 治疗物质滥用相关疾病的方法
CN1250213C (zh) 用于预防或治疗神经性疼痛和丛集性头痛及有或没有先兆的偏头痛的氨基甲酸酯化合物
CN1186336C (zh) 秦皮总香豆素的制备方法及其在制药中的应用
CN1259911C (zh) 用于预防或治疗神经性疼痛和丛集性头痛及偏头痛性疼痛的氨基甲酸酯化合物
JP4362368B2 (ja) 神経因性疼痛および群発および偏頭痛に伴う疼痛の防止または処置に使用するためのカルバメート化合物
RU2228742C2 (ru) Способ лечения рецидивирующего иридоциклохориоидита лошадей
RU2228741C2 (ru) Способ лечения рецидивирующего иридоциклохориоидита лошадей
RU2223756C1 (ru) Способ лечения рецидивирующего иридоциклохориоидита лошадей
HK1073259A (en) Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
CN101053564A (zh) 一种用于抗焦虑以及用于镇痛的药物组合物
HK1065486B (en) Carbamate compounds for use in preventing or treating neurodegenerative disorders

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C12 Rejection of a patent application after its publication
RJ01 Rejection of invention patent application after publication

Open date: 20061018